3-BROMO-2,5-DICHLOROPYRIDINE | CAS:138006-41-4

We serve 3-BROMO-2,5-DICHLOROPYRIDINE CAS:138006-41-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-BROMO-2,5-DICHLOROPYRIDINE

Chemical Name:  3-BROMO-2,5-DICHLOROPYRIDINE
CAS.NO:138006-41-4
Synonyms:  3-BROMO-2,5-DICHLOROPYRIDINE
5-Brom-2,3-dichlorpyridin
 
Molecular Formula:C5H2BrCl2N
Molecular Weight:226.88600
 
Physical and Chemical Properties:
Density:1.848g/cm3
Boiling point:239ºC at 760mmHg
Melting point:98.3ºC
Flash point:98.3ºC
Index of Refraction:1.424-1.426
 
Specification:
Appearance:White powder
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates



Contact us for information like 3-BROMO-2,5-DICHLOROPYRIDINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Brom-2,3-dichlorpyridin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Brom-2,3-dichlorpyridin Use and application,5-Brom-2,3-dichlorpyridin technical grade,usp/ep/jp grade.


Related News: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.Methyl 2-(3-(3-((7-chloroquinolin-2-yl)(thiophen-2-yl)methyl)phenyl)-3-oxopropyl)benzoate manufacturer The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.Propyl bromoacetate supplier The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.poly(allylamine hydrochloride) vendor Who is at risk of infection? People of all ages can be infected with the virus, but older people and those with pre-existing medical conditions are especially vulnerable to severe complications.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.